Shares of Alignment Healthcare, Inc. (ALHC) surged 5.07% in the past 24 hours, following the company's impressive first-quarter 2025 financial results and raised full-year guidance. The Medicare Advantage insurer reported better-than-expected earnings and revenue, demonstrating strong growth and improved profitability.

Alignment Healthcare reported a Q1 loss of $0.05 per share, significantly better than the Zacks Consensus Estimate of a $0.12 loss and an improvement from the $0.25 loss per share in the same quarter last year. Revenue for the quarter reached $926.93 million, surpassing analyst estimates of $888.35 million and representing a 47.5% year-over-year increase. The company's health plan membership grew 31.7% to approximately 217,500 members.

Investors were particularly encouraged by Alignment's raised guidance for 2025. The company increased its full-year revenue outlook to a range of $3.77 billion to $3.82 billion, up from the previous forecast. Additionally, Alignment Healthcare announced a CFO transition, with finance veteran Jim Head succeeding Thomas Freeman, who will transition to the role of Strategic Advisor to the CEO. This leadership change is viewed positively as the company enters its next growth phase.